GANEP–Nutricao Humana, Sao Paulo, Brazil.
Nutr Clin Pract. 2012 Aug;27(4):533-9. doi: 10.1177/0884533612449488. Epub 2012 Jun 22.
Digestive complications in enteral nutrition (EN) can negatively affect the nutrition clinical outcome of hospitalized patients. Diarrhea and constipation are intestinal motility disorders associated with pharmacotherapy, hydration, nutrition status, and age. The aim of this study was to analyze the frequency of these intestinal motility disorders in patients receiving EN and assess risk factors associated with diarrhea and constipation in hospitalized patients receiving exclusive EN therapy in a general hospital.
The authors performed a sequential and observational study of 110 hospitalized adult patients fed exclusively by EN through a feeding tube. Patients were categorized according to the type of intestinal transit disorder as follows: group D (diarrhea, 3 or more watery evacuations in 24 hours), group C (constipation, less than 1 evacuation during 3 days), and group N (absence of diarrhea or constipation). All prescription drugs were recorded, and patients were analyzed according to the type and amount of medication received. The authors also investigated the presence of fiber in the enteral formula.
Patients classified in group C represented 70% of the study population; group D comprised 13%, and group N represented 17%. There was an association between group C and orotracheal intubation as the indication for EN (P < .001). Enteral formula without fiber was associated with constipation (logistic regression analysis: P < .001).
Constipation is more frequent than diarrhea in patients fed exclusively by EN. Enteral diet with fiber may protect against medication-associated intestinal motility disorders. The addition of prokinetic drugs seems to be useful in preventing constipation.
肠内营养(EN)中的消化并发症会对住院患者的营养临床结局产生负面影响。腹泻和便秘是与药物治疗、水合作用、营养状况和年龄相关的肠道动力障碍。本研究的目的是分析接受 EN 的患者中这些肠道动力障碍的发生频率,并评估在综合医院接受 EN 治疗的住院患者中与腹泻和便秘相关的风险因素。
作者对 110 名通过喂养管接受 EN 喂养的成年住院患者进行了一项连续、观察性研究。根据肠道转运障碍的类型将患者分为以下三组:D 组(腹泻,24 小时内出现 3 次以上水样便)、C 组(便秘,3 天内排便少于 1 次)和 N 组(无腹泻或便秘)。记录所有处方药物,根据接受的药物类型和剂量对患者进行分析。作者还调查了肠内配方中是否含有纤维。
C 组患者占研究人群的 70%;D 组占 13%,N 组占 17%。C 组与经口气管插管作为 EN 适应证之间存在关联(P<0.001)。不含纤维的肠内配方与便秘相关(逻辑回归分析:P<0.001)。
在接受 EN 喂养的患者中,便秘比腹泻更常见。含纤维的肠内饮食可能有助于预防与药物相关的肠道动力障碍。添加促动力药物似乎有助于预防便秘。